•  
  •  
  •  
  •  

2025-10-02 10:42:45

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  MangaloreRefineryandPetrochemicals

Stock Report

  • Mangalore Refinery and Petrochemicals Ltd consolidated Q1FY26 loss at Rs. 270.66 crores
  • Mangalore Refinery and Petrochemicals Ltd Q4 FY2025 consolidated PAT up QOQ at Rs. 370.63 crores
  • MRPL achieves remarkable milestone in Crude Processing
  • Mangalore Refinery and Petrochemicals Ltd consolidated Q3FY25 PAT at Rs. 309.30 crores
  • Mangalore Refinery and Petrochemicals Ltd Q2 FY25 consolidated loss at Rs. 696.94 crores
  • Mangalore Refinery and Petrochemicals Ltd Q1FY25 consolidated PAT declines to Rs. 73.22 crores
  • MRPL recommends final dividend of Rs. 2
  • Mangalore Refinery and Petrochemicals Ltd Q4 FY2024 consolidated net profit up QOQ at Rs. 1138.50 crores
  • MRPL to increase stake in Mangalore SEZ Ltd
  • MRPL declares interim dividend of Rs. 1
  • Mangalore Refinery and Petrochemicals Ltd consolidated Q3FY24 PAT drops QOQ to Rs. 392.08 crores
  • Mangalore Refinery and Petrochemicals Ltd Q2 FY24 consolidated PAT at Rs. 1051.68 crores
  • Mangalore Refinery and Petrochemicals Ltd Q1 FY24 consolidated PAT slides to Rs. 1014.79 crores
  • Mangalore Refinery and Petrochemicals Ltd consolidated Q4 FY2023 PAT at Rs. 1913.35 crores
  • MRPL announces Q2FY22 earnings

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024